论文部分内容阅读
目的:探讨宫腔镜联合药物治疗子宫肌瘤的疗效,评价其优势作用。方法:选取我院妇科2015年9月~2017年4月期间收治的124例子宫肌瘤患者作为研究对象,将其随机分为观察组(宫腔镜联合药物治疗)和对照组(宫腔镜治疗)各62例,比较两组患者的治疗恢复情况。结果:与对照组相比,观察组患者的治疗有效率(95.16%>82.26%)相对更高,而不良反应发生率(3.23%<8.06%)相对更低,对比差异具有统计学意义(P<0.05)。结论:在子宫肌瘤的临床治疗当中,宫腔镜联合药物治疗具有显著的优势作用,其治疗有效率更高,治疗安全性更好,能够充分保障患者的身体健康,促进其快速康复。
Objective: To explore the efficacy of hysteroscopy combined with medical treatment of uterine fibroids, to evaluate its superiority. Methods: A total of 124 patients with uterine fibroids who were treated in our hospital from September 2015 to April 2017 were selected and divided into observation group (hysteroscopy combined with medical treatment) and control group (hysteroscopy Treatment) 62 cases each, compared the recovery of treatment of two groups of patients. Results: Compared with the control group, the treatment group (95.16%> 82.26%) in the observation group was relatively higher, while the incidence of adverse reactions (3.23% <8.06%) was relatively lower, with significant difference <0.05). Conclusion: Among the clinical treatment of uterine fibroids, hysteroscopy combined with medical therapy has a significant predominance effect, its treatment is more efficient and the treatment is more safe, which can fully protect the patient’s health and promote its rapid recovery.